Medicare CAP Vendor Selected

June 1, 2006

Medicare has chosen BioScrip Corp., a pharmacy services company headquartered in Elmsford, New York, as the vendor for the initial 6-month phase of its new Competitive Acquisition Program (CAP), which begins July 1. CAP gives physicians the option to obtain more than 180 Part B drugs and biologicals administered in office practices from a vendor rather than acquiring them from a distributor and then seeking reimbursement. Under CAP, BioScrip will bill Medicare for the medications, collect patients' co-pays, and handle other administrative tasks.

WASHINGTON—Medicare has chosen BioScrip Corp., a pharmacy services company headquartered in Elmsford, New York, as the vendor for the initial 6-month phase of its new Competitive Acquisition Program (CAP), which begins July 1. CAP gives physicians the option to obtain more than 180 Part B drugs and biologicals administered in office practices from a vendor rather than acquiring them from a distributor and then seeking reimbursement. Under CAP, BioScrip will bill Medicare for the medications, collect patients' co-pays, and handle other administrative tasks.